Euglycemic Diabetic Ketoacidosis Associated With Use of SGLT2 Inhibitor After Laparoscopic Roux-en-Y Gastric Bypass

Am Surg. 2021 Dec;87(12):1997-1999. doi: 10.1177/0003134820940286. Epub 2020 Aug 19.

Authors

Katherine E Yared¹, Gregory J Mancini¹

Affiliation

¹ 21823 Department of Surgery, University of Tennessee Graduate School of Medicine, Knoxville, TN, USA.

PMID: 32812784
DOI: 10.1177/0003134820940286

No abstract available

Keywords: SGLT2 inhibitor; bariatric surgery; euglycemic diabetic ketoacidosis; laparoscopic Roux-en-Y gastric bypass; starvation ketosis.

Publication types

Case Reports

MeSH terms

Diabetes Mellitus, Type 2 / complications
Diabetes Mellitus, Type 2 / drug therapy
Diabetic Ketoacidosis / chemically induced
Diabetic Ketoacidosis / etiology*
Gastric Bypass / adverse effects*
Gastric Bypass / methods
Humans
Male
Middle Aged
Obesity, Morbid / complications
Obesity, Morbid / surgery
Sodium-Glucose Transporter 2 Inhibitors / adverse effects*
Sodium-Glucose Transporter 2 Inhibitors / therapeutic use

Substances

Sodium-Glucose Transporter 2 Inhibitors